Taking Next Step in Molecular Dx Strategy, Affymetrix Seeks FDA OK for Clinical Lab | GenomeWeb
Affymetrix recently filed applications with the state of California and the US Food and Drug Administration to enable patient testing in its newly developed clinical laboratories, according to company officials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.